The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Luly Jay R. since 2014.
This trader's CIK number is 1571211.
At the time of last reporting, Luly Jay R. was the President and CEO of Enanta Pharmaceuticals Inc. (stock ticker symbol ENTA).
Also see all insider trading activities at Enanta Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ENTA | 45,000 | $256,050 | 0 | $0 | 0 | $0 |
| 2024 | ENTA | 0 | $0 | 5,142 | $41,444 | 0 | $0 |
| 2023 | ENTA | 0 | $0 | 35,142 | $1,337,303 | 27,912 | $390,768 |
| 2022 | ENTA | 0 | $0 | 0 | $0 | 24,563 | $518,351 |
| 2021 | ENTA | 0 | $0 | 4,516 | $266,696 | 0 | $0 |
| 2020 | ENTA | 0 | $0 | 0 | $0 | 15,000 | $0 |
| 2019 | ENTA | 0 | $0 | 0 | $0 | 7,052 | $99,997 |
| 2018 | ENTA | 0 | $0 | 60,000 | $7,041,238 | 8,498 | $99,987 |
| 2016 | ENTA | 0 | $0 | 0 | $0 | 85,206 | $245,402 |
| 2015 | ENTA | 0 | $0 | 45,000 | $1,799,745 | 68,700 | $102,912 |
| 2014 | ENTA | 0 | $0 | 66,600 | $2,700,051 | 258,174 | $189,241 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-12 | ENTA | Buy | 45,000 | 5.69 | 256,050 |
| 2024-12-06 | ENTA | Sale | 5,142 | 8.06 | 41,444 |
| 2023-12-05 | ENTA | Sale | 7,230 | 9.63 | 69,624 |
| 2023-03-13 | ENTA | Option Ex | 27,912 | 14.00 | 390,768 |
| 2023-03-13 | ENTA | Sale | 27,912 | 45.42 | 1,267,679 |
| 2022-12-19 | ENTA | Option Ex | 14,500 | 27.58 | 399,910 |
| 2022-01-15 | ENTA | Option Ex | 10,063 | 11.77 | 118,441 |
| 2021-09-15 | ENTA | Sale | 4,516 | 59.06 | 266,696 |
| 2020-12-15 | ENTA | Option Ex | 7,500 | .00 | 0 |
| 2019-12-16 | ENTA | Option Ex | 7,500 | .00 | 0 |
| 2019-10-08 | ENTA | Option Ex | 7,052 | 14.18 | 99,997 |
| 2018-07-27 | ENTA | Option Ex | 8,498 | 11.77 | 99,987 |
| 2018-07-05 | ENTA | Sale | 2,977 | 123.81 | 368,567 |
| 2018-07-06 | ENTA | Sale | 32,023 | 125.75 | 4,027,020 |
| 2018-05-16 | ENTA | Sale | 14,032 | 105.82 | 1,484,908 |
| 2018-05-17 | ENTA | Sale | 10,968 | 105.83 | 1,160,743 |
| 2016-06-10 | ENTA | Option Ex | 41,645 | 2.97 | 123,852 |
| 2016-05-10 | ENTA | Option Ex | 25,000 | 2.97 | 74,350 |
| 2016-03-09 | ENTA | Option Ex | 18,561 | 2.54 | 47,200 |
| 2015-10-23 | ENTA | Option Ex | 68,700 | 1.50 | 102,912 |
| 2015-03-09 | ENTA | Sale | 15,000 | 34.03 | 510,390 |
| 2015-02-20 | ENTA | Sale | 15,000 | 35.35 | 530,295 |
| 2015-01-05 | ENTA | Sale | 15,000 | 50.60 | 759,060 |
| 2014-12-12 | ENTA | Option Ex | 7,055 | .73 | 5,171 |
| 2014-12-01 | ENTA | Sale | 15,000 | 45.98 | 689,625 |
| 2014-11-03 | ENTA | Sale | 15,000 | 42.71 | 640,680 |
| 2014-04-01 | ENTA | Sale | 15,000 | 39.95 | 599,250 |
| 2014-03-10 | ENTA | Sale | 10,000 | 38.56 | 385,650 |
| 2014-02-14 | ENTA | Sale | 5,800 | 38.16 | 221,339 |
| 2014-01-10 | ENTA | Option Ex | 251,119 | .73 | 184,070 |
| 2014-01-02 | ENTA | Sale | 5,800 | 28.19 | 163,507 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Luly Jay R. (President and CEO of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.